Abstract

Most Rapidly spreading arboviral infection across various states of our country is Dengue Fever. It is spread by Aedes aegypti mosquito which harbors Dengue virus, which is a RNA virus belonging to family Flaviviridae. The patient affected by Dengue presents with asymptomatic infection to complications like Dengue haemorrhagic fever and Dengue Shock Syndrome. Most common manifestations include high fever of acute onset, muscle and joint pain, cutaneous rash, myalgia, hemorrhagic episodesand circulatory rash. Early and accurate diagnosis is critical to reduce mortality.

• 1.   National Institute of Health. Available at https: //www.niaid.nih.gov/diseases-conditions/ dengue-fever.
• 2.   Gupta N, Srivastava S Jain A, Chaturvedi UC. Dengue in India. Indian Journal of Medical Research 2012; 136; 373-90.
• 3.   Geneva Switzerland: WHO 2009, WHO. Dengue: Guidelines for diagnosis, Treatment, Prevention and Control. Part 1.1.6: Dengue case classification; pp. 10-2.
• 4.   (Waterman SH, Gubler DJ, Dengue fever. Clinical Dermatology. 1989; 7;117-22.).
• 5.   (Gubler DJ. Dengue and dengue Hemorrhagic fever. Clin Microbiol Rev. 1998;11:480–96.
• 6.   (Ahmed FU, Mahmood CB, Sharma JD, Hoque SM, Zaman R, Hasan MH. Dengue fever and dengue haemorrhagic fever in chidren the 2000 out break in Chittatong, Bangladesh. Dengue Bulletin. 2001;25:33–9.
• 7.   (National Institute of Communicable Diseases. Investigation and Control of Outbreaks: Dengue and Dengue Hemorrhagic Fever. 1997.
• 8.   Gurugama P, Garg P, Perera J, Wijewickrama A, Seneviratne SL. Dengue viral infections. Indian J Dermatol. 2010;55(1):68–78. doi: 10.4103/0019-5154.60357.
• 9.   Shivpuri A, Shivpuri A. Dengue – An over view. Dent Med Probl. 2011;48(2):153–6.
• 10.   Darvin Scott Smith et al, Dengue Differential Diagnoses. MedscapeUpdated: Dec 14, 2024.
• 11.   Chaterji S, Allen JC Jr, Chow A, Leo YS, Ooi EE. Evaluation of the NS1 rapid test and the WHO dengue classification schemes for use as bedside diagnosis of acute dengue fever in adults. Am J Trop Med Hyg. 2011 Feb. 84(2):224-8.
• 12.   Potts JA, Rothman AL. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations. Trop Med Int Health. 2008 Nov. 13(11):1328-40.
• 13.   (Bottieau E, Clerinx J, Van den Enden E, Van Esbroeck M, Colebunders R, Van Gompel A. Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions. Medicine (Baltimore). 2007 Jan. 86(1):18-25.
• 14.   Guideline CDC. Clinical Testing Guidance for Dengue. Centers for Disease Control and Prevention. Available at https://www.cdc. gov/dengue/hcp/diagnosis-testing. August 26, 2024; Accessed: December 14, 2024.
• 15.   Malhotra N, Chanana C, Kumar S. Dengue infection in pregnancy. Int J Gynaecol Obstet. 2006 Aug. 94(2):131-2.
• 16.   A. Rather, H.A. Parray, J.B. Lone, W.K. Paek J. Lim, V.K. Bajpai, Y.H. Park Prevention and control strategies to counter dengue virus infection Front. Cell. Infect. Microbiol., 7 (2017), p. 336.
• 17.   W.H. Wang, A.N. Urbina, M.R. Chang, W. Assavalapsakul, P.L. Lu, Y.H. Chen, S.F. Wang. Dengue hemorrhagic fever–a systemic literature review of current perspectives on pathogenesis, prevention and control. J. Microbiol. Immunol. Infect., 53 (6) (2020), pp. 963-978.
• 18.   T. Pang, T.K. Mak, D.J. Gubler. Prevention and control of dengue—the light at the end of the tunnel. Lancet Infect. Dis., 17 (3) (2017), pp. e79-e87
• 19.   A. Abidemi, N.A. Aziz. Optimal control strategies for dengue fever spread in Johor,Malaysia. Comput. Methods Prog. Biomed., 196 (2020), Article 105585.
• 20.   W.H. Wang, A.N. Urbina, M.R. Chang, W. Assavalapsakul, P.L. Lu, Y.H. Chen, S.F. Wang Dengue hemorrhagic fever–a systemic literature review of current perspectives on pathogenesis, prevention and control J. Microbiol. Immunol. Infect., 53 (6) (2020), pp. 963-978.
• 21.   H.J. Kuo, K. Lee, J.W. Liu Analyses of clinical and laboratory characteristics of dengue adults at their hospital presentations based on the World Health Organization clinical-phase framework: emphasizing risk of severe dengue in the elderly J. Microbiol. Immunol. Infect., 51 (6) (2018), pp. 740-748
• 22.   L.C. Katzelnick, L. Gresh, M.E. Halloran, J.C. Mercado, G. Kuan, A. Gordon, A. Balmaseda, E. Harris Antibody-dependent enhancement of severe dengue disease in humans Science, 358 (6365) (2017), pp. 929-932.
• 23.   S.B. Halstead, S. Mahalingam, M.A. Marovich, S. Ubol, D.M. Mosser Intrinsic antibodydependent enhancement of microbial infection in macrophages: disease regulation by immune complexes Lancet Infect. Dis., 10 (10) (2010), pp. 712-722.
• 24.   S.R. Hadinegoro, J.L. ArredondoGarcía, M.R. Capeding, C. Deseda, T. Chotpitayasunondh, R. Dietze, Hj Muhammad Ismail, H.I., Reynales, H., Limkittikul, K., Rivera-Medina, D.M. and Tran, H.N. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease N. Engl. J. Med., 373 (13) (2015), pp. 1195-1206..
• 25.   M. Aguiar, N. Stollenwerk, S.B. Halstead The impact of the newly licensed dengue vaccine in endemic countries PLoS Negl. Trop. Dis., 10 (12) (2016), Article e0005179.
• 26.   X. Yang, M.B. Quam, T. Zhang, S. Sang Global burden for dengue and the evolving pattern in the past 30 years J. Travel Med., 28 (8) (2021).
• 27.   A. Wilder-Smith TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden Lancet Glob. Health, 12 (2) (2024), pp. e179-e180.
• 28.   E.G. Kallás, M.A. Cintra, J.A. Moreira, E.G. Patiño, P.E. Braga, J.C. Tenório, V. Infante, R. Palacios, M.V.G. de Lacerda, D. Batista Pereira, A.J. da Fonseca Live, attenuated, tetravalent Butantan–Dengue vaccine in children and adults New England J. Med., 390 (5) (2024), pp. 397-408.
• 29.   E. Prompetchara, C. Ketloy, S.J. Thomas, K. Ruxrungtham Dengue vaccine: Global development update Asian Pac. J. Allergy Immunol., 38 (3) (2020), pp. 178-185.
• 30.   C.H. Huang, Y.T. Tsai, S.F. Wang, W.H. Wang, Y.H. Chen Dengue vaccine: an update Expert Rev. Anti-Infect. Ther., 19 (12) (2021), pp. 1495- 1502 ).
• 31.   W.H.O.I. Dengue Guidelines for diagnosis, treatment Prev. Control., No Title (2009).
• 32.   V. Kamath, A.B. Aishwarya Dengue vaccines: current status and future perspectives APIK J. Int. Med. (2024), pp. 10-4103.

Data Sharing Statement

Funding